Search research articles
Contact Us
Filters
Showing results (391-400 of 476) with videos related to
Page
of 48
Sort By:
T. Brookhaven National Laboratory
|
February 19, 2014
Medical survey of Rongelap people five and six years after exposure to fallout (with an addendum on vegetation)
R A CONARD, H E MACDONALD, A LOWREY, et al.
Cognitive, Affective & Behavioral Neuroscience
|
February 2, 2023
Uncertain threat is associated with greater impulsive actions and neural dissimilarity to Black versus White faces
Estée Rubien-Thomas, Nia Berrian, Kristina M Rapuano, et al.
Dementia and Geriatric Cognitive Disorders
|
August 9, 2017
Effectiveness of Florbetapir PET Imaging in Changing Patient Management
Michael J Pontecorvo, Andrew Siderowf, Bruno Dubois, et al.
Nature Communications
|
December 2, 2023
Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primates
Chaim A Schramm, Damee Moon, Lowrey Peyton, et al.
Elife
|
April 13, 2013
Usf1, a suppressor of the circadian Clock mutant, reveals the nature of the DNA-binding of the CLOCK:BMAL1 complex in mice
Kazuhiro Shimomura, Vivek Kumar, Nobuya Koike, et al.
Biorxiv : the Preprint Server for Biology
|
October 17, 2024
mRNA-based influenza vaccine expands breadth of B cell response in humans
Hanover C Matz, Tae-Geun Yu, Julian Q Zhou, et al.
Nature Immunology
|
June 15, 2026
mRNA-based influenza vaccine expands the B cell response breadth in humans
Hanover C Matz, Tae-Geun Yu, Kritika Dixit, et al.
Journal of Environmental Radioactivity
|
July 30, 2017
Measurements of Argon-39 at the U20az underground nuclear explosion site
J I McIntyre, C E Aalseth, T R Alexander, et al.
Journal of Environmental Radioactivity
|
September 19, 2019
Migration of noble gas tracers at the site of an underground nuclear explosion at the Nevada National Security Site
C Johnson, C E Aalseth, T R Alexander, et al.
Blood Advances
|
February 10, 2025
Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia
Athalia R Pyzer, Laura W Dillon, Elad Sharon, et al.
Page
of 48
Search research articles
Search
Showing results (391-400 of 476) with videos related to
Sort By:
Page
of 48
T. Brookhaven National Laboratory
|
February 19, 2014
Medical survey of Rongelap people five and six years after exposure to fallout (with an addendum on vegetation)
R A CONARD, H E MACDONALD, A LOWREY, et al.
Cognitive, Affective & Behavioral Neuroscience
|
February 2, 2023
Uncertain threat is associated with greater impulsive actions and neural dissimilarity to Black versus White faces
Estée Rubien-Thomas, Nia Berrian, Kristina M Rapuano, et al.
Dementia and Geriatric Cognitive Disorders
|
August 9, 2017
Effectiveness of Florbetapir PET Imaging in Changing Patient Management
Michael J Pontecorvo, Andrew Siderowf, Bruno Dubois, et al.
Nature Communications
|
December 2, 2023
Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primates
Chaim A Schramm, Damee Moon, Lowrey Peyton, et al.
Elife
|
April 13, 2013
Usf1, a suppressor of the circadian Clock mutant, reveals the nature of the DNA-binding of the CLOCK:BMAL1 complex in mice
Kazuhiro Shimomura, Vivek Kumar, Nobuya Koike, et al.
Biorxiv : the Preprint Server for Biology
|
October 17, 2024
mRNA-based influenza vaccine expands breadth of B cell response in humans
Hanover C Matz, Tae-Geun Yu, Julian Q Zhou, et al.
Nature Immunology
|
June 15, 2026
mRNA-based influenza vaccine expands the B cell response breadth in humans
Hanover C Matz, Tae-Geun Yu, Kritika Dixit, et al.
Journal of Environmental Radioactivity
|
July 30, 2017
Measurements of Argon-39 at the U20az underground nuclear explosion site
J I McIntyre, C E Aalseth, T R Alexander, et al.
Journal of Environmental Radioactivity
|
September 19, 2019
Migration of noble gas tracers at the site of an underground nuclear explosion at the Nevada National Security Site
C Johnson, C E Aalseth, T R Alexander, et al.
Blood Advances
|
February 10, 2025
Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia
Athalia R Pyzer, Laura W Dillon, Elad Sharon, et al.
Page
of 48